A 5-year Clinical Trial Assessing the Effects of a Surface Sealant on Composite Resin Class I Restorations
1 other identifier
interventional
10
0 countries
N/A
Brief Summary
This trial, based on a split mouth and double-blind design, will evaluate the effects of a surface sealant on the clinical performance of composite resin class I restorations. According to eligibility criteria, 10 pairs of upper and lower molars or premolars will be restored with Esthet X composite resin. For each pair, one surface will be sealed with Lasting Touch surface sealant. A clinical evaluation will be performed by two experienced operators using modified USPHS (United States Public Health service) after 5 years after treatment. Data will be analyzed using the McNemar test (p \< 0.05).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Apr 2011
Longer than P75 for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 4, 2016
CompletedFirst Posted
Study publicly available on registry
September 14, 2016
CompletedSeptember 14, 2016
September 1, 2016
6 months
September 4, 2016
September 13, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Resin composite Longevity
A clinical evaluation will be performed by two experienced operators using modified USPHS (United States Public Health service) at baseline, before the treatment. The parameters included will be marginal discoloration, anatomic form, secondary caries and marginal integrity.
baseline
Secondary Outcomes (1)
Resin composite longevity
5-year
Study Arms (2)
No Surface Sealant
EXPERIMENTALResin composite only
With surface Sealant
ACTIVE COMPARATORResin composite with surface sealant application
Interventions
Device: * Enamel and dentin etching with 37% phosphoric acid (Scotchbond Etchant; 3M/ESPE, St. Paul, MN, USA) for 30 s and 15 s. * Two coats of one-bottle adhesive (Adper TM Single Bond 2, 3M/ESPE, St. Paul, MN, USA) will be applied homogeneously to the surface with a disposable micro-brush. * Cavities will be restored with 2 mm increments of composite resin (Z350, 3M/ESPE, St. Paul, MN, USA) * 7 Days after: Finishing and polishing will be performed with fine diamond and multilaminated burs, one step polishing system Pogo (Dentsply, Caulk, USA). * The composite surface and 1 mm external limit will be etched with a 37% acid phosphoric and after will be covered using a nanotechnology liquid polish system (Lasting Touch, Dentsply Caulk, Milford, DE, USA).
Device: * Enamel and dentin etching with 37% phosphoric acid (Scotchbond Etchant; 3M/ESPE, St. Paul, MN, USA) for 30 s and 15 s. * Two coats of one-bottle adhesive (Adper TM Single Bond 2, 3M/ESPE, St. Paul, MN, USA) will be applied homogeneously to the surface with a disposable micro-brush. * Cavities will be restored with 2 mm increments of composite resin (Z350, 3M/ESPE, St. Paul, MN, USA) * 7 Days after: Finishing and polishing will be performed with fine diamond and multilaminated burs, one step polishing system Pogo (Dentsply, Caulk, USA).
Eligibility Criteria
You may qualify if:
- Good oral hygiene;
- Having a class I caries lesion or unsatisfactory restoration in at least two posterior teeth (molar or premolar);
- Be in agreement and sign the consent form.
You may not qualify if:
- Patients with a proximal caries lesion;
- Presence of periodontal disease;
- Presence of symptomatic restored or non restored teeth indicating irreversible pulpal pathology;
- Presence of an abnormal occlusion or the absence of antagonist teeth;
- Presence of exposure of pulpal tissue;
- Presence of extended or large cavities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 4, 2016
First Posted
September 14, 2016
Study Start
April 1, 2011
Primary Completion
October 1, 2011
Study Completion
June 1, 2016
Last Updated
September 14, 2016
Record last verified: 2016-09